Janus Henderson Group PLC lessened its position in Waters Co. (NYSE:WAT) by 6.9% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 1,700,752 shares of the medical instruments supplier’s stock after selling 126,684 shares during the period. Janus Henderson Group PLC owned approximately 2.45% of Waters worth $366,067,000 as of its most recent filing with the SEC.
Other institutional investors have also recently made changes to their positions in the company. Massey Quick Simon & CO. LLC purchased a new position in shares of Waters during the first quarter valued at approximately $43,000. Financial Gravity Wealth Inc. purchased a new position in shares of Waters during the first quarter valued at approximately $63,000. Thor Advisors LLC purchased a new position in shares of Waters during the first quarter valued at approximately $64,000. Whittier Trust Co. boosted its position in shares of Waters by 23.0% during the first quarter. Whittier Trust Co. now owns 369 shares of the medical instruments supplier’s stock valued at $93,000 after buying an additional 69 shares during the last quarter. Finally, Parallel Advisors LLC boosted its position in shares of Waters by 285.7% during the first quarter. Parallel Advisors LLC now owns 405 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 300 shares during the last quarter. 96.08% of the stock is owned by hedge funds and other institutional investors.
Several research analysts recently issued reports on the company. Robert W. Baird cut their target price on Waters from $211.00 to $209.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 24th. Zacks Investment Research raised Waters from a “sell” rating to a “hold” rating and set a $217.00 target price on the stock in a research report on Wednesday, May 22nd. Bank of America cut Waters from a “neutral” rating to an “underperform” rating in a research report on Tuesday, July 16th. Cleveland Research cut Waters from a “neutral” rating to an “underperform” rating in a research report on Wednesday, June 12th. Finally, Barclays cut their price objective on Waters from $218.00 to $210.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 24th. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. Waters presently has an average rating of “Hold” and a consensus price target of $210.54.
Waters (NYSE:WAT) last issued its earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.11 by $0.03. The firm had revenue of $599.20 million for the quarter, compared to analyst estimates of $601.46 million. Waters had a return on equity of 50.64% and a net margin of 24.09%. The business’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.95 earnings per share. As a group, research analysts predict that Waters Co. will post 9.01 earnings per share for the current year.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Further Reading: What is diluted earnings per share (Diluted EPS)?
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.